Exploring Key Insights of the Neurovascular Embolization Devices Market: Growth Prospects, Emerging Trends, and Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the neurovascular embolization devices market grown over the years?
The market size for neurovascular embolization devices has seen robust growth recently. It is projected to increase from $1.32 billion in 2024 to $1.4 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. The expansion during the historical period is due to factors such as the escalating occurrence of neurovascular ailments, the growing population of older people, the preference for minimally invasive surgeries, advancements in healthcare infrastructure, and heightened healthcare spending.
What Is the forecasted market size and growth rate for the neurovascular embolization devices market?
Robust expansion is anticipated for the neurovascular embolization devices market over the next few years, with the market size forecasted to surge to $1.8 billion by 2029, progressing at a compound annual growth rate (CAGR) of 6.5%. The projected escalation during this period can be linked to an enlarged scope of applications in nascent markets, a growing focus on patient-oriented healthcare, heightened knowledge surrounding neurovascular maladies, enhancements in imaging technology, and a rise in R&D investments. Key trends foreseen in this duration encompass tailor-made treatment methodologies, the inclusion of AI in treatment design, introduction of cutting-edge embolic materials, a shift in preference towards outpatient and ambulatory procedures, and the creation of groundbreaking embolization techniques.
Get your neurovascular embolization devices market report here!
What are the major factors driving growth in the neurovascular embolization devices market?
An uptick in the frequency of hemorrhages is projected to boost the advancement of the neurovascular embolization devices market. Hemorrhages entail abnormal, unregulated internal or external bleeding, often via a tear in the skin or mucous membrane. This increase in occurrence is attributable to a variety of aspects, such as an aging demographic, greater instances of hypertension, and the broadening application of anticoagulant drugs. Neurovascular embolization devices are deployed in hemorrhagic strokes to block defective blood vessels, lessen bleeding, and avert additional harm to the brain. For instance, research conducted by King’s College London in February 2024 projected a 59.4% increase in the number and mortality of intracerebral hemorrhage (ICH), a specific form of hemorrhage, in the UK by 2050 in citizens aged 70 to 95. Therefore, this surge in the frequency of hemorrhages is propelling the growth of the neurovascular embolization devices market.
What key areas define the segmentation of the global neurovascular embolization devices Market?
The neurovascular embolization devices market covered in this report is segmented –
1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Ischemic Stroke Solution, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
2) By Liquid Embolic Systems: Gluteraldehyde-Based Liquid Embolization, Onyx Liquid Embolic System
3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips
5) By Other Products: Balloons For Embolization, Microcatheters
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15871&type=smp
What are the top market players propelling the growth of the neurovascular embolization devices industry?
Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc., Penumbra Inc., Asahi Intecc Co Ltd., MicroVention Inc., Balt USA LLC, Imperative Care Inc., InNeuroCo Inc., Acandis GmbH & Co KG, Rapid Medical Ltd., Emboline Inc., InspireMD Inc., QXMedical LLC, Vesalio LLC, EmbolX Inc
What emerging trends are influencing the growth of the neurovascular embolization devices market?
Prominent market players in the neurovascular embolization device sector are concentrating their efforts on crafting products that utilize break-through technology like Shield Technology, with a vision to treat brain aneurysms and solidify their competitive standing in the market. Shield Technology is an advanced feature designed to boost the efficiency and security of the devices, contributing to the device’s overall longevity and durability. As an example, a healthcare technology company based in Ireland, Medtronic PLC, introduced the fourth-generation flow diverter, the Pipeline Vantage with Shield Technology, to the Indian market in June 2022. This device comes with innovative design features that enhance usability and reliability during endovascular procedures. The device stimulates cell growth in the blood vessel’s inner lining and offers a support structure that aids in the non-invasive treatment of aneurysms, lowers the chance of rupture, and enhances patient outcomes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15871
What regions are dominating the neurovascular embolization devices market growth?
North America was the largest region in the neurovascular embolization devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Uterine Fibroid Embolization Device Global Market Report 2024
Neurofibromatosis Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report
Tumor Embolization Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
